Top Page
AnteoTech Ltd
(Sydney:ADO)
AnteoTech Ltd (ADO) vs. iShares MSCI Australia ETF (EWA)
AnteoTech Ltd Business Overview & Revenue Model
AnteoTech Ltd Financial Statement Overview
| Breakdown | |||||
| TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| -545.39K | 460.40K | 365.72K | 760.88K | 898.07K | 299.40K | Gross Profit |
| -545.39K | 460.40K | 365.72K | 760.88K | 898.07K | 1.27M | EBIT |
| -11.53M | -12.77M | -13.35M | -12.73M | -7.74M | -4.10M | EBITDA |
| -8.00M | -11.57M | -14.86M | -12.07M | -7.18M | -3.67M | Net Income Common Stockholders |
| -8.72M | -8.88M | -12.65M | -10.72M | -6.22M | -3.13M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 7.38M | 5.03M | 2.72M | 10.10M | 21.39M | 3.21M | Total Assets |
| 11.54M | 9.38M | 5.36M | 15.26M | 23.68M | 3.91M | Total Debt |
| 2.27M | 2.31M | 1.31M | 1.03M | 1.28M | 134.87K | Net Debt |
| -5.11M | -2.71M | -1.41M | -9.07M | -20.11M | -3.08M | Total Liabilities |
| 3.84M | 4.08M | 2.99M | 2.91M | 2.56M | 699.63K | Stockholders Equity |
| 7.70M | 5.31M | 2.38M | 12.36M | 21.11M | 3.21M |
| Cash Flow | Free Cash Flow | ||||
| -6.94M | -7.58M | -8.77M | -11.77M | -4.76M | -2.77M | Operating Cash Flow |
| -6.32M | -6.52M | -8.08M | -8.65M | -4.55M | -2.50M | Investing Cash Flow |
| -570.63K | -1.06M | -690.83K | -3.12M | -213.07K | -270.45K | Financing Cash Flow |
| 9.63M | 9.89M | 1.39M | 482.29K | 22.94M | 1.71M |
AnteoTech Ltd Technical Analysis
AnteoTech Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
53 Neutral | $5.14B | 3.23 | -45.01% | 2.85% | 17.55% | -0.69% | |
40 Underperform | AU$21.64M | ― | -140.07% | ― | 62.15% | 33.93% | |
| $279.43M | ― | -133.28% | ― | ― | ― | ||
| $279.39M | ― | -31.16% | ― | ― | ― | ||
64 Neutral | AU$18.38M | 140.00 | -3.11% | ― | 89.13% | 69.57% | |
54 Neutral | AU$246.70M | ― | -37.20% | ― | ― | 32.02% | |
53 Neutral | AU$696.11M | ― | -56.99% | ― | 10.76% | -195.89% |
AnteoTech Ltd Corporate Events
AnteoTech Ltd has formalized an employment agreement with Ms. Merrill Gray, who has stepped into the role of Interim CEO and Managing Director from her previous position as a Non-Executive Director. The agreement, effective from April 16, 2025, to October 16, 2025, includes a base remuneration and a daily rate for CEO services, with performance-based incentives tied to strategic milestones. This leadership transition is expected to guide the company through its strategic review and align its operations with revised strategies, potentially impacting its market positioning and stakeholder interests.
AnteoTech Ltd has announced the cessation of Mr. David Radford as a director effective April 22, 2025. Mr. Radford, through Lucremont Pty Ltd, holds significant interests in the company, including ordinary shares and a substantial number of unlisted options. This change in directorship may influence the company’s strategic direction and stakeholder interests, given Mr. Radford’s notable shareholding and involvement in the company.
AnteoTech Ltd has released its quarterly cashflow report and activities update for the period ending March 31, 2025, highlighting significant developments in its advanced battery technologies and life sciences divisions. The company is advancing its Ultranode™ technology, targeting the consumer electronics and e-Mobility markets, and is engaged in evaluations with major global chemical companies and Mercedes-Benz. In life sciences, AnteoTech is pursuing increased orders from the Serum Institute of India and negotiations with Vidcare. The company is undergoing strategic and cultural reviews to align its resources for growth, with a focus on sales, marketing, and cost management. Despite challenges in the global EV market, AnteoTech remains committed to leveraging its innovative technology suite to unlock shareholder value.
AnteoTech Ltd announced it will release its March Quarterly Appendix 4C and Report on April 30, 2025, accompanied by a webinar hosted by Interim CEO and Managing Director, Ms. Merrill Gray. This announcement indicates the company’s ongoing commitment to transparency and engagement with stakeholders, potentially impacting its market positioning and investor relations.
AnteoTech Ltd has appointed Ms. Merrill Gray as the Interim CEO and Managing Director, following Mr. Radford’s decision to step down. Ms. Gray brings over 30 years of experience in mineral processing and energy transitioning, with a focus on critical minerals and battery materials supply chains. Her appointment is expected to advance the commercialisation of AnteoTech’s products and technologies in the clean energy and life sciences markets, leveraging her expertise in emerging global markets.
AnteoTech Ltd announced the cessation of Mr. Ewen Crouch as a director effective April 14, 2025. The notice details Mr. Crouch’s interests in securities, which include ordinary shares and various options held through Wersley Investments Pty Ltd and Wersley Pty Ltd atf Ewen Crouch Family Trust. This change in the board could impact the company’s strategic direction and stakeholder interests.
AnteoTech Ltd has appointed Ms. Glenda McLoughlin as the new non-executive Chair, effective April 1, 2025. Ms. McLoughlin brings over 20 years of experience on listed company boards and has previously chaired the Audit and Risk Committee and the Energy Advisory Board. This leadership change follows a strategic refocusing of the company towards the commercialization of its AnteoBind™ and Anteo X™ technologies, as well as the development of its Ultranode™ technology and pilot plant construction. The company is now well-positioned to advance its commercial pipeline, thanks to the groundwork laid by outgoing Chair Mr. Ewen Crouch AM and Dr. Katherine Woodthorpe AO.
AnteoTech Ltd announced the retirement of independent non-executive directors Ewen Crouch AM and Dr. Katherine Woodthorpe AO, effective April 14, 2025. This change in the board could impact the company’s strategic direction, and stakeholders are awaiting the announcement of the next Chair. The company continues to focus on its core markets of clean energy and life sciences, leveraging its proprietary technologies to maintain a competitive edge.